Skip to content

Clinical study on effect of Viddhakarma Therapy in management of Episcleritis (Sirotpat)

Single-arm clinical study to evaluate the efficacy of Viddhakarma in the management of Sirotpat with special reference to Episcleritis - NIL

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2026/03/106317
Enrollment
35
Registered
2026-03-16
Start date
Unknown
Completion date
Unknown
Last updated
2026-03-30

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: H151- Episcleritis

Interventions

None listed

Sponsors

Sane Guruji Arogya Kendra
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1]Patients satisfying following classical symptoms a. Vedana (pain) b. Raktrajit shukla(congestion) c. Dah/Ushyate(burning sensation) d. Ashof-ashru-updeha(No swelling, discharge) 2]Age group: 19-60 years 3]Irrespective of gender

Exclusion criteria

Exclusion criteria: 1]Patients with corneal injury,corneal ulcer or iridocyclitis 2]Patients with malignancies or contagious diseases 3]Patients with known bleeding disorders

Design outcomes

Primary

MeasureTime frame
Decrease in symptoms such as Vedana (pain), Raktrajit shukla(congestion), Dah/Ushyate(burning sensation), Ashof-ashru-updeha(No swelling, discharge)Timepoint: Follow up on 2nd and 5th day. Symptoms will be noted. Observational follow up on 7th day.

Secondary

MeasureTime frame
NILTimepoint: NIL

Countries

India

Contacts

Public ContactProf Dr Sumedha Kotangale

MAMS Sumatibhai Shah Ayurved Mahavidyalaya

sumedhayk@yahoo.com8275298480

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Apr 4, 2026